WebAdmin 35 0 0 4 min to read

The FDA has granted an EUA for an anti-Covid pill.

The Food and Drug Administration (FDA) has issued an anti-Covid pill emergency use authorization (EUA) after it was first used in a few hospitals under a compassionate special permit (CSP).

FDA Director-General Eric Domingo said the antiviral molnupiravir, marketed under the brand name Molnarz, can now be used by adults 18 and older with mild to moderate symptoms of Covid-19, as well as those at risk of developing severe illnesses, such as senior citizens and people with comorbidities, in a televised Laging Handa public briefing on Thursday.

“It’s available in 200-milligram capsules…

He continued, “Hindi po ito puwede sa mga severe o iyong mga nangangailangan na ng oxygen (this is not for patients with severe symptoms or those who require oxygen).”

Within five days after the onset of symptoms, the pill (800 mg) can be taken twice a day for five days. Otherwise, the sufferers would be unable to benefit from it.

Because data on its safety in this category of patients is currently lacking, it is not recommended for pregnant or lactating women.

While the FDA will no longer issue CSPs for the use of molnupiravir, hospitals with supplies should still follow the EUA requirements for procurement, distribution, and reasonable drug use of Covid-19 medicines.

“Because ito ay kailangang dumaan pa rin po sa mga (Because ito ay kailangang dumaan pa rin po sa mga (Because ito ay kailangang dumaan pa rin po sa mga (Because ito ay kailangang dumaan pa rin po sa mga ( “This has to go through the Department of Health’s laws and regulations,” Domingo explained. (

Please follow and like us:
Tweet 2k
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

Enjoy this blog? Please spread the word :)

Would love your thoughts, please comment.x